Literature DB >> 23975469

Antitumor effect of the LIVP-GFP recombinant vaccinia virus.

I S Petrov1, E P Goncharova, I V Kolosova, S G Pozdnyakov, S N Shchelkunov, M A Zenkova, V V Vlasov.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23975469     DOI： 10.1134/S0012496613040133

Source DB:  PubMed          Journal:  Dokl Biol Sci        ISSN： 0012-4966


× No keyword cloud information.
  10 in total

1.  Antiviral chemotherapy facilitates control of poxvirus infections through inhibition of cellular signal transduction.

Authors:  Hailin Yang; Sung-Kwon Kim; Mikyung Kim; Pedro A Reche; Tiara J Morehead; Inger K Damon; Raymond M Welsh; Ellis L Reinherz
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

Review 2.  Targeted oncolytic herpes simplex viruses for aggressive cancers.

Authors:  Jennifer Wong; Cleo Lee; Kevin Zhang; Paul S Rennie; William Jia
Journal:  Curr Pharm Biotechnol       Date:  2012-07       Impact factor: 2.837

3.  The role of thymidine kinase in cancer diseases.

Authors:  Ondrej Topolcan; Lubos Holubec
Journal:  Expert Opin Med Diagn       Date:  2008-02

4.  Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors.

Authors:  Hiroaki Wakimoto; Santosh Kesari; Christopher J Farrell; William T Curry; Cecile Zaupa; Manish Aghi; Toshihiko Kuroda; Anat Stemmer-Rachamimov; Khalid Shah; Ta-Chiang Liu; Deva S Jeyaretna; Jason Debasitis; Jan Pruszak; Robert L Martuza; Samuel D Rabkin
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

5.  The confirmation and maintenance of smallpox eradication.

Authors:  J G Breman; I Arita
Journal:  N Engl J Med       Date:  1980-11-27       Impact factor: 91.245

6.  Chemosensitivity testing of human colorectal carcinoma cell lines using a tetrazolium-based colorimetric assay.

Authors:  J G Park; B S Kramer; S M Steinberg; J Carmichael; J M Collins; J D Minna; A F Gazdar
Journal:  Cancer Res       Date:  1987-11-15       Impact factor: 12.701

7.  Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus.

Authors:  Qian Zhang; Yong A Yu; Ena Wang; Nanhai Chen; Robert L Danner; Peter J Munson; Francesco M Marincola; Aladar A Szalay
Journal:  Cancer Res       Date:  2007-10-15       Impact factor: 12.701

Review 8.  Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses.

Authors:  Z Sheng Guo; Stephen H Thorne; David L Bartlett
Journal:  Biochim Biophys Acta       Date:  2008-02-15

9.  The oncolytic poxvirus JX-594 selectively replicates in and destroys cancer cells driven by genetic pathways commonly activated in cancers.

Authors:  Kelley A Parato; Caroline J Breitbach; Fabrice Le Boeuf; Jiahu Wang; Chris Storbeck; Carolina Ilkow; Jean-Simon Diallo; Theresa Falls; Joseph Burns; Vanessa Garcia; Femina Kanji; Laura Evgin; Kang Hu; Francois Paradis; Shane Knowles; Tae-Ho Hwang; Barbara C Vanderhyden; Rebecca Auer; David H Kirn; John C Bell
Journal:  Mol Ther       Date:  2011-12-20       Impact factor: 11.454

10.  Theranostic potential of oncolytic vaccinia virus.

Authors:  Juan J Rojas; Steve H Thorne
Journal:  Theranostics       Date:  2012-04-05       Impact factor: 11.556
  10 in total
  5 in total

1.  New p35 (H3L) Epitope Involved in Vaccinia Virus Neutralization and Its Deimmunization.

Authors:  Yana Khlusevich; Andrey Matveev; Lyudmila Emelyanova; Elena Goncharova; Natalia Golosova; Ivan Pereverzev; Nina Tikunova
Journal:  Viruses       Date:  2022-06-05       Impact factor: 5.818

2.  Virotherapy of the Malignant U87 Human Glioblastoma in the Orthotopic Xenotransplantation Mouse SCID Model.

Authors:  S N Shchelkunov; I A Razumov; I V Kolosova; A V Romashchenko; E L Zavjalov
Journal:  Dokl Biochem Biophys       Date:  2018-03-14       Impact factor: 0.834

3.  Oncolytic virus efficiency inhibited growth of tumour cells with multiple drug resistant phenotype in vivo and in vitro.

Authors:  Elena P Goncharova; Julia S Ruzhenkova; Ivan S Petrov; Sergey N Shchelkunov; Marina A Zenkova
Journal:  J Transl Med       Date:  2016-08-18       Impact factor: 5.531

4.  Effect of the Route of Administration of the Vaccinia Virus Strain LIVP to Mice on Its Virulence and Immunogenicity.

Authors:  Sergei N Shchelkunov; Stanislav N Yakubitskiy; Alexander A Sergeev; Alexei S Kabanov; Tatiana V Bauer; Leonid E Bulychev; Stepan A Pyankov
Journal:  Viruses       Date:  2020-07-24       Impact factor: 5.048

5.  Enhancing the Protective Immune Response to Administration of a LIVP-GFP Live Attenuated Vaccinia Virus to Mice.

Authors:  Sergei N Shchelkunov; Stanislav N Yakubitskiy; Kseniya A Titova; Stepan A Pyankov; Alexander A Sergeev
Journal:  Pathogens       Date:  2021-03-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.